- Pharmaceutical companies
- Asia
- Japan
- Novartis
Novartis in Japan
Addresses:
-
Novartis Holding Japan K.K., Toranomon Hills, Mori Tower, 1-23-1, Toranomon, Minato-Ku, Tokyo 105-6333, Japan
Phone: 81 3 6899 8000
Fax: 81 3 6257 3634
-
Novartis Pharma K.K., Sasayama Plant, 25-1, Hioki, Sasayama-shi, Sasayama, Hyogo 669-2441, Japan
Phone: 81 79 556 4000
Fax: 81 79 556 4030
-
Novartis Pharma K.K., Toranomon Hills, Mori Tower, 1-23-1, Toranomon, Minato-ku, Tokyo 105-6333, Japan
Phone: 81 3 6899 8000
Fax: 81 3 6257 3634
-
Sandoz K.K., Fukuoka Site, 3-2-1 Hakata-Ekimae, Hakata-ku, Fukuoka 812-0011, Japan
Phone: 81 92 433 7870
Fax: 81 92 686 7971
-
Sandoz K.K., Kaminoyama Site, 827-7, Shinkanaya, Kaminoyama-shi, Yamagata 999-3102, Japan
Phone: 81 23 673 5225
Fax: 81 23 672 8166
-
Sandoz K.K., Nagoya Office, Marunouchi ST Bldg. 9F, 2-20-25, Marunouchi, Naka-ku, Nagoya-shi, Nagoya, Aichi 460-0002, Japan
Phone: 81 52 229 1730
Fax: 81 52 229 1731
-
Sandoz K.K., Toranomon Hills, Mori Tower, 1-23-1, Toranomon, Minato-ku, Tokyo 105-6333, Japan
Phone: 81 3 6899 7000
Fax: 81 3 6257 3630
Other Novartis's locations around the world
-
Switzerland
-
Austria
-
Germany
-
Slovenia
-
Poland
-
France
-
Spain
-
Belgium
-
Romania
-
Italy
-
United Kingdom
-
Ukraine
-
Russia
-
Serbia
-
Slovakia
-
Sweden
-
Belarus
-
Bulgaria
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Macedonia
-
Malta
-
Montenegro
-
Netherlands
-
Norway
-
Portugal
-
Albania
-
Bosnia & Herzegovina
Clinical Trials sponsored by Novartis
-
Novartis PharmaceuticalsHar ikke rekruttert ennåAnti-nøytrofile cytoplasmaantistoffer (ANCA) assosiert vaskulitt
-
Novartis PharmaceuticalsHar ikke rekruttert ennåMultippel sklerose, tilbakefallende-remitterende
-
Novartis PharmaceuticalsHar ikke rekruttert ennåLeddgikt | Systemisk lupus erythematosus | Sjögrens sykdom
-
Novartis PharmaceuticalsHar ikke rekruttert ennåForhøyet Lp(a) og etablert aterosklerotisk kardiovaskulær sykdom
-
Novartis PharmaceuticalsRekrutteringTilbakevendende former for multippel skleroseSpania
-
Novartis PharmaceuticalsRekruttering
-
Novartis PharmaceuticalsHar ikke rekruttert ennå
-
Novartis PharmaceuticalsRekrutteringMultippel sklerose (MS)Frankrike
-
Novartis PharmaceuticalsHar ikke rekruttert ennå
-
Novartis PharmaceuticalsRekrutteringHR+HER2- Avansert brystkreftDen russiske føderasjonen
About Novartis
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.